Estimation of very-low-density lipoprotein cholesterol from data on triglyceride concentration in plasma. 1981

P W Wilson, and R D Abbott, and R J Garrison, and W P Castelli

We examined the relationship in a large-living population between the concentration of triglycerides in plasma from fasting persons and the concentration of very-low-density lipoprotein cholesterol (VLDL-C) as determined after preparative ultracentrifugation. Data from individuals in the Framingham Heart Study who were free of coronary heart disease, did not have Fredrickson Type I, III, or V hyperlipoproteinemia, and whose plasma-triglyceride values were less than 4000 mg/L were considered in the analyses. A total of 4100 Framingham Offspring, ages 20-49 years, met these criteria, as did 2284 participants in the original Framingham Cohort, aged 50-79 years. We estimated a linear regression model with an intercept and slope coefficient, using VLDL-C (units, mg/L) as the dependent variable and triglycerides as the dependent variable. The intercept was approximately 30.0 mg/L, and the slope coefficient for triglycerides was about 0.20 when all age and sex groups were combined. However, when the analysis was performed by age group, the slope coefficient for triglycerides increased with each age group only for women. The model, in which a different intercept and slope is used for each age and sex group was statistically better than a previously developed simpler model. On the other hand, the older model, in which VLDL-C is easily estimated by multiplying the triglyceride value by 0.20, is reasonably accurate and is very simple to use. The generalizability of the model is discussed in the light of results from other population studies.

UI MeSH Term Description Entries
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

P W Wilson, and R D Abbott, and R J Garrison, and W P Castelli
January 1985, Arteriosclerosis (Dallas, Tex.),
P W Wilson, and R D Abbott, and R J Garrison, and W P Castelli
March 1977, Journal of lipid research,
P W Wilson, and R D Abbott, and R J Garrison, and W P Castelli
April 2017, BMC medicine,
P W Wilson, and R D Abbott, and R J Garrison, and W P Castelli
March 2022, Laboratory medicine,
P W Wilson, and R D Abbott, and R J Garrison, and W P Castelli
March 1975, Scandinavian journal of clinical and laboratory investigation,
P W Wilson, and R D Abbott, and R J Garrison, and W P Castelli
January 1985, Monographs on atherosclerosis,
P W Wilson, and R D Abbott, and R J Garrison, and W P Castelli
October 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
P W Wilson, and R D Abbott, and R J Garrison, and W P Castelli
May 1979, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!